Jefferies analyst Roger Song downgrades CytomX Therapeutics (NASDAQ:CTMX) from Buy to Hold and lowers the price target from $12 to $2.
Cue Health Launches Pharmacy Offering To Empower Individuals To Manage Common Health And Wellness Needs From Home
Cue now offers over-the-counter and prescription medications for sexual health, birth control, hair loss, and more
Cue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced an